Q4 2020 Holdings
Filed 2021-02-16 | 15 holdings | $1.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $940.0K | 10,719 | 55.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $501.0K | 4,676 | 29.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $260.0K | 2,000 | 15.2% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $729 | 3,085 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $703 | 11,327 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $439 | 8,000 | 0.0% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $389 | 1,944 | 0.0% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $375 | 2,094 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $353 | 4,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $322 | 2,788 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $304 | 5,847 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $296 | 3,089 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $295 | 3,240 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $287 | 3,740 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $223 | 12,091 | 0.0% |